Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls
How to Cite
OrthoEvidence. Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls. ACE Report. 2019;8(1):24. Available from: https://myorthoevidene.com/AceReport/Report/10252
Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and metaanalysisExpert Opin Drug Saf. 2018 Apr;17(4):413-428
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
6 randomized controlled trials were included in this meta-analysis which aimed to compare increase in bone mineral density measurements between denosumab and other active anti-osteoporosis medications among postmenopausal women with osteoporosis and who had previously been administered anti-osteoporosis therapy. In pooled analyses, percent increase in bone mineral density measured at the total hip...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE